Why the study?
Does diabetes impair microvascular reactivity in patients with acute coronary syndrome?
Does diabetes impair microvascular reactivity in patients with acute coronary syndrome?
Microvascular reactivity is severely impaired in patients with both diabetes and acute coronary syndrome, highlighting the major influence of diabetes on microvascular function in CAD.
Answers are grounded in this paper and cite their sources.
Diabetes may impair microvascular reactivity in ACS; hypothesis-generating and requires prospective studies before clinical implications.
BACKGROUND: Microvascular function is impaired in patients with stable coronary artery disease. The aim was to study microvascular function in patients with diabetes and acute coronary syndrome (ACS). METHODS: Microvascular function was evaluated in 83 patients by laser Doppler fluxmetry (LDF) [PU; perfusion unit, median (interquartile range)] measuring resting LDF and peak LDF following a six min heating of the skin to 44 °C at the foot, respectively. All patients with ACS and without previously known diabetes underwent oral glucose tolerance test. Thirty-nine patients with type 2 diabetes mellitus free from coronary artery disease served as controls. RESULTS: Peak LDF was significantly (P = 0.03) lower in patients with ACS and diabetes (n = 22; 72 (52)) and diabetes without coronary artery disease (n = 39; 69 (51)) as compared to patients with ACS without diabetes (n = 46; 97 (60)), and patients without ACS (n = 15; 140 (121)), respectively. Patients with ACS (n = 68) had significantly (P = 0.04) lower peak LDF (92 (49)) as compared to patients without ACS (n = 15) (140 (121)). CONCLUSION: Microvascular reactivity is severely impaired in patients with diabetes and ACS. Diabetes has a major influence on microvascular function in patients with coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Papadogeorgos et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: